Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Teva Pharmaceutical Industries Ltd. (TEVA) had Weighted-Average Shares Outstanding (Diluted) of 1.16B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$17.26B |
|
$1.41B |
|
$8.32B |
|
$8.94B |
|
$15.10B |
|
$2.16B |
|
$-934.00M |
|
$1.22B |
|
$1.22B |
|
$1.40B |
|
$1.42B |
|
$1.42B |
|
$1.40B |
|
$2.16B |
|
$3.16B |
|
1.15B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.16B |
$1.23 |
|
$1.21 |
|
| Balance Sheet Financials | |
$13.95B |
|
$4.08B |
|
$26.80B |
|
$40.75B |
|
$13.46B |
|
$14.99B |
|
$19.38B |
|
$32.83B |
|
$7.91B |
|
$-11.87B |
|
$7.91B |
|
1.15B |
|
| Cash Flow Statement Financials | |
$1.65B |
|
$737.00M |
|
$-2.15B |
|
$3.30B |
|
$3.56B |
|
$256.00M |
|
$157.00M |
|
$-340.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
0.65 |
|
2.12 |
|
51.79% |
|
12.50% |
|
12.50% |
|
18.31% |
|
7.09% |
|
8.17% |
|
$1.18B |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
2.62 |
|
4.65 |
|
78.44 |
|
17.92% |
|
-11.95% |
|
3.48% |
|
6.19% |
|
$6.88 |
|
$1.02 |
|
$1.42 |
|